Skinvisible (SKVI) Operating Margin (2010 - 2026)
Skinvisible's (SKVI) quarterly Operating Margin came in at 2256.34% in Q2 2026, up 46840.0% year-over-year from N/an in Q2 2025, and up 10.42% quarter-over-quarter from 2518.76% in Q1 2026.
Powered by 
Analysis
Skinvisible (SKVI) Operating Margin (2010 - 2026) Analysis & Trends
Skinvisible has disclosed Operating Margin across 17 years of filings, most recently posting 2256.34% for Q2 2026.
- In Q2 2026, Operating Margin rose 46840.0% year-over-year to 2256.34%; the TTM figure through Jun 2026 stood at 2294.91% (up 70410.0% YoY), while the FY2025 annual figure was 2481.57%, up 46637.0% from the prior year.
- Operating Margin came in at 2256.34% for Q2 2026 at Skinvisible, up from 2518.76% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 41.95% in Q2 2022 to a low of 3974.86% in Q4 2024.
- Average Operating Margin over 5 years is 2228.37%, with a median of 2409.0% recorded in 2022.
- Year-over-year, Operating Margin tumbled 242547 bps in 2023 and soared 169148 bps in 2025.
- Over 5 years, Operating Margin stood at 2354.32% in 2022, then retreated by 16 bps to 2730.76% in 2023, then plunged by 46 bps to 3974.86% in 2024, then soared by 43 bps to 2283.38% in 2025, then advanced by 1 bps to 2256.34% in 2026.
- Per Business Quant data, the three most recent Operating Margin figures were 2256.34% in Q2 2026, 2518.76% in Q1 2026, and 2283.38% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 648.23 Bn | 627.47 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 443.69 Bn | 437.12 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.29 Bn | 361.15 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 270.18 Bn | 262.49 Bn | 11.24 Bn | 32.97% |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 28.37% |
| 6 | Sanofi | 52.93 Bn | 45.55 Bn | 10.79 Bn | 9.03% |
| 7 | Revolution Medicines | 44.15 Bn | 44.15 Bn | - | - |
| 8 | Incyte | 25.21 Bn | 20.68 Bn | 1.57 Bn | 41.69% |
| 9 | United Therapeutics | 21.11 Bn | 18.44 Bn | 683.80 Mn | 42.23% |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | -2,256.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,256.34% |
| Mar 31, 2026 | -2,518.76% |
| Dec 31, 2025 | -2,283.38% |
| Sep 30, 2025 | -2,121.14% |
| Jun 30, 2025 | -2,724.74% |
| Mar 31, 2025 | -2,797.04% |
| Dec 31, 2024 | -3,974.86% |
| Sep 30, 2024 | -2,499.38% |
| Jun 30, 2024 | -2,853.86% |
| Mar 31, 2024 | -2,463.68% |
| Dec 31, 2023 | -2,730.76% |
| Sep 30, 2023 | -2,262.20% |
| Jun 30, 2023 | -2,256.46% |
| Mar 31, 2023 | -2,558.08% |
| Dec 31, 2022 | -2,354.32% |
| Sep 30, 2022 | -1,365.04% |
| Jun 30, 2022 | 41.95% |
| Mar 31, 2022 | -132.61% |
| Dec 31, 2021 | 58.35% |
| Sep 30, 2021 | -7.05% |